Qiagen NV | QIA - Interest Income

Stock Price
35.33
Daily Change
-0.27 -0.74%
Monthly
-13.80%
Yearly
-2.77%
Q1 Forecast
35.13

Qiagen NV reported $15.07M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
argenx SE USD 42.7M 4.3M Sep/2025
Dianthus Therapeutics USD 3.66M 255K Sep/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
IQVIA Holdings USD 13M 3M Sep/2025
Moderna USD 73M 8M Sep/2025
Qiagen NV USD 15.07M 1.21M Sep/2025
Revvity USD 0.4 8.34M Sep/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
Xeris Pharmaceuticals USD 1.16M 210K Sep/2025